Cite
Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity
MLA
Ian Pike, et al. “Vaccination with Post-Translational Modified, Homocitrullinated Peptides Induces CD8 T-Cell Responses That Mediate Antitumor Immunity.” Journal for ImmunoTherapy of Cancer, vol. 11, no. 10, Oct. 2023. EBSCOhost, https://doi.org/10.1136/jitc-2023-006966.
APA
Ian Pike, Victoria A Brentville, Peter Symonds, Katherine W Cook, Lindy G Durrant, Sabaria Shah, Samantha J Paston, Juliane Weißer, Anne Skinner, & Abdullah Al Omari. (2023). Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity. Journal for ImmunoTherapy of Cancer, 11(10). https://doi.org/10.1136/jitc-2023-006966
Chicago
Ian Pike, Victoria A Brentville, Peter Symonds, Katherine W Cook, Lindy G Durrant, Sabaria Shah, Samantha J Paston, Juliane Weißer, Anne Skinner, and Abdullah Al Omari. 2023. “Vaccination with Post-Translational Modified, Homocitrullinated Peptides Induces CD8 T-Cell Responses That Mediate Antitumor Immunity.” Journal for ImmunoTherapy of Cancer 11 (10). doi:10.1136/jitc-2023-006966.